ZyVersa Therapeutics
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Employees
- 7
- Market Cap
- -
- Website
- http://www.zyversa.com
- Introduction
ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases. The company was founded by Stephen C. Glover in 2014 and is headquartered in Weston, FL.
P2a Open Label Study to Evaluate 2-HPβCD in Subjects with Diabetic Kidney Disease
- First Posted Date
- 2024-07-05
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- ZyVersa Therapeutics, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT06489340
© Copyright 2025. All Rights Reserved by MedPath